These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14083963)

  • 1. CONTROL EXPERIENCE WITH INVESTIGATIONAL NEW DRUGS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1963; 17():27-37. PubMed ID: 14083963
    [No Abstract]   [Full Text] [Related]  

  • 2. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION.
    KELSEY FO
    J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363
    [No Abstract]   [Full Text] [Related]  

  • 3. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 4. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    SD J Med Pharm; 1964 Mar; 17():42-5. PubMed ID: 14126560
    [No Abstract]   [Full Text] [Related]  

  • 5. INVESTIGATIONAL DRUG REGULATIONS AND CLINICAL RESEARCH.
    GIBSON ML
    J Oral Ther Pharmacol; 1964 Jul; 1():93-8. PubMed ID: 14204421
    [No Abstract]   [Full Text] [Related]  

  • 6. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    J New Drugs; 1963; 3(6):377-80. PubMed ID: 14113562
    [No Abstract]   [Full Text] [Related]  

  • 7. [RESPONSIBILITY OF THE PHYSICIAN IN THE ADMINISTRATION OF NEW DRUGS (INVESTIGATIONAL PREPARATIONS, PARTICULARLY UNREGISTERED DRUGS)].
    KOHLHAAS M
    Munch Med Wochenschr; 1964 Dec; 106():2281-8. PubMed ID: 14336570
    [No Abstract]   [Full Text] [Related]  

  • 8. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 9. RESPONSIBILITY FOR TESTING DRUGS IN HUMANS.
    DOWLING HF
    JAMA; 1964 Jan; 187():212-5. PubMed ID: 14067988
    [No Abstract]   [Full Text] [Related]  

  • 10. RULES, REGULATIONS AND RESEARCH.
    NEIBEL OJ
    New Physician; 1963 Dec; 12():A85-A87. PubMed ID: 14103668
    [No Abstract]   [Full Text] [Related]  

  • 11. ASPECTS OF DEVELOPMENT OF NEW DRUGS.
    KLUMPP T
    IMJ Ill Med J; 1963 Oct; 124():307-13. PubMed ID: 14067809
    [No Abstract]   [Full Text] [Related]  

  • 12. INFORMED CONSENT: SHOULD NEW DRUGS BEGET NEW LAWS?
    SCHROEDER OC
    Postgrad Med; 1963 Dec; 34():A26-A31. PubMed ID: 14103037
    [No Abstract]   [Full Text] [Related]  

  • 13. PROOF OF NEW DRUG EFFICACY.
    LEVIN M
    Mil Med; 1965 Jul; 130():695-7. PubMed ID: 14301148
    [No Abstract]   [Full Text] [Related]  

  • 14. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE PHYSICIAN AS FINAL ARBITER?
    PAGE I
    Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073
    [No Abstract]   [Full Text] [Related]  

  • 16. [ANIMAL AND HUMAN EXPERIMENTATION WITH NEW DRUGS].
    MARCONI M; DOMINICI A
    Clin Ter; 1964 Jun; 29():562-81. PubMed ID: 14184056
    [No Abstract]   [Full Text] [Related]  

  • 17. REGULATIONS AFFECTING DRUG RESEARCH AND DEVELOPMENT: A HISTORICAL PERSPECTIVE.
    KLUMPP TG
    J New Drugs; 1963; 3(4):212-20. PubMed ID: 14063357
    [No Abstract]   [Full Text] [Related]  

  • 18. Liability in use of investigational drugs.
    SCHREINER GE
    JAMA; 1963 Jul; 185():259-63. PubMed ID: 13987033
    [No Abstract]   [Full Text] [Related]  

  • 19. RECENT EXPERIENCES WITH EFFECTIVE NEW DRUG APPLICATIONS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1964; 18():1-6. PubMed ID: 14224959
    [No Abstract]   [Full Text] [Related]  

  • 20. The FDA's response to AIDS: paradigm shift in new drug policy?
    Podraza R
    Food Drug Law J; 1993; 48(3):351-75. PubMed ID: 11653267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.